Researchers use the CLS to study enzymatic pathways in <em>Chlamydia</em> in order to develop more effective antibiotics.

July 12, 2011

Bacteria from the genus Chlamydia cause a number of serious health conditions in humans. As antibiotic resistance increases in these organisms, methods of combating infections are becomming increasingly urgent. Researchers from the University of Alberta are using the Canadian Macromolecular Crystallography Facility in their investigation of an alternate route of lysine biosynthesis in Chlamydia that is an excellent target for the development of new and specific antibiotics.